Pleural Effusions Devices Market
Report ID: SQMIG35A3341
Report ID: SQMIG35A3341
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3341 |
Region:
Global |
Published Date: March, 2026
Pages:
157
|Tables:
116
|Figures:
77
Global Pleural Effusions Devices Market size was valued at USD 250.0 Million in 2024 and is poised to grow from USD 267.25 Million in 2025 to USD 455.76 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
The primary driver of the pleural effusion devices market is the aging population and growing rates of cardiopulmonary and oncologic diseases, creating increased demand for diagnostics and drainages. The market includes devices used to diagnose, manage, and palliate pleural fluids such as thoracentesis kits, indwelling pleural catheters, chest tubes, and vacuum systems. This is significant because effective devices decrease length of stay, decrease complications from procedures, and increase the quality of life for patients with either malignancies or benign effusions. The last decade has seen increases in adoption rates due to the emergence of minimally invasive procedures, outpatient environments, and bundled reimbursement models; an example of this is the increased use of indwelling catheters in oncology.
Increasing rates of adoption are being further accelerated by the recent development of reimbursement policies, as favorable coding and outpatient payments create an incentive for hospitals and clinics to invest in ambulatory drainage solutions. By expanding coverage for outpatient thoracentesis and indwelling catheters, insurance companies enable providers to move patients from the hospital to outpatient infusion centers, providing an overall reduction in cost of care and driving the sales of pleural effusion devices.
How is AI Improving Diagnostic Accuracy in the Pleural Effusion Devices Market?
To improve the diagnostic precision of pleural effusion products, artificial intelligence (AI) combines the use of imaging enhancement, automated fluid quantification and cytology image analysis. Improved imaging interpretation, less variability in bedside imaging by operators and faster clinical decision making support clinicians in their choice of thoracentesis or other treatment options. Currently, AI systems provide clinicians with augmentation of ultrasound and CT scans and assist in the laboratory workflow by providing whole slide images. The market now includes companies that make devices with integrated software and sensors to enable the delivery of more reliable and objective results. Reports from clinical studies and reviews up to now demonstrate better accuracy in detecting and classifying the presence of pleural disease. In June of this year the Exo obtained d FDA approval for an ultrasound AI that allows clinicians to access real time green light indicators, thus speeding diagnosis at the bedside and decreasing uncertainty in detection. This innovation will enable continued growth in the market for the manufacturers of products that will allow for the use of objective AI tools at both the manufacturer and provider levels will lead to increased use of these devices.
Market snapshot - (2026-2033)
Global Market Size
USD 250.0 Million
Largest Segment
Thoracentesis Kits/Needles
Fastest Growth
Indwelling Pleural Catheters (IPC)
Growth Rate
6.9% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global pleural effusions devices market is segmented into device category, drainage method, indication, end-user and region. Based on device category, the market is segmented into thoracentesis kits/needles, indwelling pleural catheters (IPC), pleurodesis systems and pleural drainage shunts. Based on drainage method, the market is segmented into gravity-based drainage and active/vacuum-assisted suction. Based on indication, the market is segmented into malignant pleural effusion and non-malignant. Based on end-user, the market is segmented into hospitals & tertiary care centers, specialized pulmonology clinics and ambulatory surgical centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per pleural effusions devices market forecast, indwelling pleural catheters (IPC) segment leads because these devices enable long term outpatient management and reduce the need for repeated hospital procedures, aligning with palliative care priorities and clinician preferences. Now they can receive these services at home due to the availability and use of an indwelling pleural catheter (IPC). An IPC can be used for long periods without needing to replace the catheter and is being used in conjunction with palliative care plans. For example, IPCs allow patients to fully participate in their care by supporting self-drainage and allowing providers to provide continuity of care. Therefore, there has been an increase in the adoption of IPCs by healthcare providers who focus on improving the quality of life for their patients. Additionally, because IPCs are so widely accepted clinically, there are now additionaldevices being developed that improve safety and comfort, which further establishes their importance to the Pleural Effusion Device Marketplace.
As per pleural effusions devices market outlook, pleurodesis systems are emerging as the most rapidly expanding area due to innovation in less invasive agents and delivery methods, rising clinician preference for durable fluid control, and increasing use in interventional suites. Furthermore, innovations in delivery devices and agents have created a new level of convenience and comfort for both patients and clinicians; as a result, the adoption of pleurodesis devices will only continue to increase within the Pleural Effusion Device Marketplace.
The active vacuum assisted suction segment leads with pleural effusions devices market share provides an efficient method of managing the drainage of pleural effusions. With the ability to utilize a controlled continuous drainage method, the use of the active vacuum-assisted approach is associated with shorter procedure times, less risk for complications, and a greater clinician satisfaction with their ability to manage a complex effusion efficiently and reliably. Recent advances in technology and the introduction of portable suction and suction with built-in safety controls have improved the ease of use of these devices across all care settings. The total benefits of improved performance and workflow provided by a vacuum-assisted suction have led to the choice of using vacuum-assist devices for pleasure drainage as a key technology in the pleural effusions devices market.
As per pleural effusions devices market analysis, gravity based drainage is witnessing the strongest growth momentum because its simplicity and suitability for home and ambulatory care attract providers seeking low resource solutions. The emergence of improved portable collection devices and more user-friendly devices has provided an opportunity for patientsto manage their own drain, leading to expanded outpatient usage and continued opportunities for device deployment within the pleural effusions devices market.
To get detailed segments analysis, Request a Free Sample Report
North America is the largest continent in the world for the production and use of pleural effusion devices due to substantial clinical knowledge, modern healthcare systems, and advantages in data innovation and advanced technology. Established clinical processes and highly cooperative working relationships between the clinical and manufacturing communities allow for rapid adoption of minimally invasive techniques and digital products.
The supply of pleural effusion devices in the United States flows from numerous dedicated centers of excellence, a broad adoption of early clinical technology, and the proximity of manufacturers who develop the newest products. The defined integrated care processes outlined above, along with a large number of research institutions, allow for a quick assessment of emerging technology. Large hospitals have extensive purchasing facilities for these devices and established training programs to implement scalable, minimally invasive procedures. The collaboration among the industry and research institutions is a significant contributor to empowering clinicians who use these devices, thereby accelerating validation of clinical outcomes.
The Canada pleural effusions devices market is based on providing equal access to medical devices in the provincial healthcare systems, creating demand for dependable sources of surgical equipment. Affiliated health networks within regions strive to implement standardized care and base their purchasing decisions on evidence-based assessments. Strong relationships between the various provincial procurement organizations and clinical communities have encouraged the trial of less invasive treatment options. Dedicated stocking distributors provide comprehensive support for training and maintenance of products to ensure consistent performance in all clinical settings.
The pleural effusions devices market is rapidly growing in Europe due to harmonized regulatory frameworks, increasing focus on outpatient and minimally invasive services, and robust clinical networks that provide real-world evidence to encourage new device use. Investment in cross-border partnerships and pilot programs also facilitates dissemination of innovative drainage and monitoring technologies throughout health care systems. Payers are increasingly focusing on outcomes, value and procurement of devices that shorten hospital stays and increase patient comfort. Localized manufacturing and a large network of specialized suppliers enable distribution and post-sale service; clinician organizations and professional education initiatives help develop standardized skills so that wider use of pleural effusion devices occurs across multiple practice settings.
As per pleural effusions devices industry analysis, Germany is supported by many manufacturers, advanced hospitals and collaborations between clinical researchers, which assist in developing and refining devices. Manufacturers use rigorous evaluations to create high-quality evidence and involve clinicians in new procedures. Engineering companies work closelywith clinicians, allowing for rapid advancements; after sale support networks allow for reliable use of products across all types of health care facilities.
In the United Kingdom, the pleural effusions devices market is experiencing rapid clinical uptake, driven by the emphasis on patient pathways favoring minimally invasive treatment options. The priority for local and regional health systems has been to reduce the amount of time patients spend in hospital; therefore, pilot programs focusing on minimizing hospital resources for patients have also been prioritized. The increased engagement of clinicians and professional organizations to promote the values of best practice means that the dissemination of good practice will continue to be vital. The introduction of new and innovative delivery models in the community and outpatient settings provides manufacturers with the opportunity to demonstrate value to patients while enhancing their overall experience.
The pleural effusions devices market in France is emerging through an increased interest in minimally invasive methods supported by centres of academic research and specializedpulmonary centres. An emphasis on the need for clinical evidence and system integration into care pathways is critical for translating new ideas into clinical practice. Publically funded hospitals and outpatient clinics are currently involved in the early stages of the pilot assessment of device usability and patient experience. Specific local partnerships have been established between medical device manufacturers and clinical researchers; these partnerships are designed to provide tailored solutions and enhance the capability to broaden the use of the products in their respective markets.
Growing investments into local manufacturers, the expansion of clinical capabilities, and strategic alliances that enhance access to devices with localized designs are some of the ways that the Asia Pacific region is developing its positioning in the pleural effusions devices market. The increasing reliance on outpatient services and shorter lengths of stay in hospitals have fueled the growing need for compact, easy-to-use pleural effusions devices able to deliver quality outcomes across a variety of clinical settings. Supplier partnerships between international manufacturers and local distributors enable a more resilient supply chain and expanded service networks.
As per pleural effusions devices market regional forecast, Japan market is supported by advanced medical technologies, large hospital networks, and collaboration among clinicians and manufacturers on product development. The focus on precision and reliability leads to the development of sophisticated diagnostic and drainage solutions for use in both acute care and outpatient settings. In addition to facilitating collaboration on product development and providing professional education and support for pulmonary specialists, there are specialized training programs for pulmonary technicians available so that new procedures can be disseminated throughout pulmonary centres.
As per pleural effusions devices market regional outlook, South Korea is supported by a vibrant medical device industry, strong partnerships between technology companies and clinical locations, and rapid product development through an innovative regulatory process. Compact and high-quality device design is consistent with growth ambitions related to increased use of outpatient care. Collaborative activities among hospitals and manufacturers enable ongoing product testing and refinement. A focus on exports and the formation of strategic alliances with international companies help to improve technology transfer and expand access to the marketplace throughout the Asia Pacific region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Technological Advancements in Devices
The rapid evolution of medical devices and techniques for diagnosing and treating pleural effusions has enhanced diagnostic accuracy and therapeutic success, resulting in increased clinician confidence and preference for device utilization. Greater patient comfort and shorter procedure time encourages hospital departments and outpatient centers to utilize devices, and the integration of these devices into digital health systems allows for improved workflow and care coordination. The concomitant qualitative benefits of devices support both purchasing decisions by healthcare providers, as well as investment in devices by manufacturers. As a result, this facilitates continued product innovation, the growth of the product market, and ultimately the development of greater perceived value for devices and clinical acceptance.
Increased Incidence of Comorbidities
The rapidly increasing elderly population with an expanding number of comorbidities and increasing susceptibility to pulmonary-related complications will create demand for effective, easy-to-use pleural effusion management devices, as clinicians look for more ways to improve patient care and shorten the duration of hospitalization. The clinical need for safer and less invasive procedures in frail individuals drives the utilization of both chest drainage systems and image-guided imaging methods throughout the care continuum. The prevalence of this elderly population encourages manufacturers to develop products and education/training programs specifically for geriatric care environments, thus further supporting market growth through targeted clinical utility.
High Procedure Costs and Reimbursement
Overhead for obtaining a device and procedure is increasing, and reimbursement processes are not being implemented consistently across some of the medical systems, preventing greater adoption types of devices and procedure by hospitals and clinics. If reimbursement is not sufficient to meet the actual cost of the devices or the procedures that were performed, the procurement process will target devices and procedures with lower overall costs, resulting in slowdown of capital investments. These types of financial constraints are creating delays in the diffusion of new technologies, discouraging smaller hospitals from utilizing specialized pleural management type devices, and as a result, will slow overall market growth regardless of the clinical demand for these types of devices, as well.
Availability of Qualified Clinicians
The lack of skilled clinicians with the ability to perform advanced pleural procedures and the techniques associated with the devices limits the number of providers that will use these devices in their practice since successful use of the devices will depend on the skill and confidence of the operator. The type of training needed, and the amount of time needed to be successful can inhibit the facilities from using the new device style when there is a large amount of turnover or not a lot of educational resources available to support the clinicians of the facility. When an adequate amount of training and clinical support is not available, facilities will either under-utilize the device or use alternate methods that are not ideal for the situation. This barrier to obtaining human resources slows down the overall market for all care sites and slows down how quickly newer devices will be considered to be the standard.
Request Free Customization of this report to help us to meet your business objectives.
The global pleural effusions devices industry is highly competitive and focused on several aspects: product differentiation/access for payers/enabling home-based care. To capture both hospital/ambulatory channels, companies are pursuing acquisitions, clinical partnerships, and device innovations. Examples are BD's development of low profile catheter kits that integrate digital monitoring, Rocket Medical's collaboration with NIHR to create a dual lumen catheter, and Pleural Dynamics receiving FDA clearance for their fully implantable shunt.
Minimally Invasive Procedure Adoption: Physicians are increasingly choosing minimally invasive techniques for draining fluid from the chest, creating a need for image-guided devices, catheter drainage systems and percutaneous approaches to being developed. Along with this shift toward use of tools that will decrease procedure times, enhance patient comfort and increase recovery times has encouraged manufacturers to create ergonomic kits and systems that are easy to use. Adoption is further aided by multidisciplinary pathways of care as well as training initiatives that have been instituted to decrease barriers to use, while product differentiation to the physician has focused on ease of use, sterility and disposability, leading to further use of devices by all different types of facilities including the hospital and outpatient settings.
Home and Ambulatory Care Growth: The pleural effusions devices market trend toward home/ambulatory care management has increased demand for portable, user-friendly devices for treating pleural effusion that fit into outpatient workflows with remote monitoring. Manufacturers are placing significant importance on product compactness, the ease of use of consumables and making products single-use to facilitate safe and reproducible care in non-traditional inpatient locations. The integration of telehealth platforms to create additional oversight of the clinician over the patient and increase patient compliance in addition to the partnership with home health agencies or ambulatory care facilities will help to increase overall use of the equipment. An emphasis on improving patient care has driven innovations throughout product development and service delivery.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global pleural effusions devices industry is propelled primarily by aging populations and rising cardiopulmonary and oncologic disease rates while technological advances including AI and portable suction systems provide an additional pleural effusions devices market growth driver by improving diagnostic accuracy and enabling outpatient care. Adoption concentrates in North America supported by strong clinical networks and favorable reimbursement frameworks and indwelling pleural catheters dominate the product landscape due to outpatient and palliative management advantages. Market expansion is tempered by high procedure costs and inconsistent reimbursement in some systems that limit broader adoption. Manufacturers focusing on user-friendly home-based solutions and payer engagement are best positioned to capture growth.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 250.0 Million |
| Market size value in 2033 | USD 455.76 Million |
| Growth Rate | 6.9% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Pleural Effusions Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pleural Effusions Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pleural Effusions Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Pleural Effusions Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Pleural Effusions Devices Market size was valued at USD 250.0 Million in 2024 and is poised to grow from USD 267.25 Million in 2025 to USD 455.76 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
Competitive dynamics in the global pleural effusion devices market revolve around product differentiation, payer access, and enabling home based care; competitors pursue acquisitions, clinical partnerships, and device innovation to win hospital and ambulatory channels. Examples include BD advancing low profile catheter kits with digital monitoring integrations, Rocket Medical partnering with NIHR on a dual lumen catheter, and Pleural Dynamics securing FDA clearance for a fully implantable shunt. 'Medtronic', 'Atrium Medical', 'Teleflex', 'Boston Scientific', 'Cook Medical', 'Olympus Corporation', 'Baxter International', 'Smiths Medical', 'Halyard Health', 'Argon Medical Devices', 'Becton Dickinson', 'Stryker Corporation', 'Cardinal Health', 'Merit Medical Systems', 'Fresenius Kabi', 'Johnson & Johnson', 'Rocialle', 'Philips Healthcare', 'Kimal plc', 'Romed SA'
Rapid improvements in device design, imaging integration, and minimally invasive techniques have elevated diagnostic accuracy and therapeutic outcomes for pleural effusions, increasing clinician confidence and preference for device-based interventions. Enhanced patient comfort and reduced procedure times support broader adoption across hospital departments and outpatient facilities, while interoperability with digital health systems streamlines workflow and care coordination. These qualitative benefits encourage procurement by healthcare providers and investment by manufacturers, fostering product innovation and market expansion through enhanced perceived value and clinical acceptance.
Minimally Invasive Procedure Adoption: Minimally invasive approaches are increasingly preferred for pleural effusion management, driving demand for devices optimized for image guidance, catheter based drainage and percutaneous interventions. Clinicians favor tools that reduce procedure time, enhance patient comfort and enable faster recovery, prompting manufacturers to design ergonomic kits and integrated systems. Adoption is supported by multidisciplinary care pathways and training initiatives that lower barriers, while product differentiation centers on ease of use, sterility and disposability, enabling wider uptake across hospitals and ambulatory procedural suites.
Why does North America Dominate the Global Pleural Effusions Devices Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
